MDGEF Message Board Post 10739222 | Medigene Ag Ord
home / stock / mdgef / mdgef message board
wmsanders1
(investorshangout)
Posted on: Sep/29/2016 08:02:37
Source: investorshangout
https://investorshangout.com/post/view?id=4085214
dhovekamp42: Attention will come with this 1st commercial TCR immunotherapy deal of German Medigene AG with Blueb
News, Short Squeeze, Breakout and More Instantly...
-
Planegg/Martinsried, July 23, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today announced the presentation of two posters...
-
Planegg/Martinsried, July 3, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, announces today that the Company has been issued...
-
Planegg/Martinsried, June 27, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today provides a detailed overview of its lead ...